Skip to main content
Article thumbnail
Location of Repository

Cell fate conversion by mRNA

By Mo Li, Ignacio Sancho-Martinez and Juan Carlos Izpisua Belmonte


Recent development of a synthetic mRNA-based technology for efficient reprogramming to pluripotency and cell fate conversion without any modification to the genome has generated great interest among researchers and clinicians alike. It is hoped that this technology could contribute to unmet needs on several fronts of regenerative medicine, including mechanistic study of reprogramming, generation of safe induced pluripotent stem cells suitable for clinical applications, and derivation of desired cell types for cell-replacement therapy. We will discuss the technological advancements made by this synthetic mRNA methodology, its implications, as well as the challenges that lie ahead in the field of regenerative medicine

Topics: Commentary
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. Activation of pluripotency genes in human fi broblast cells by a novel mRNA based approach.
  2. (2010). Bonehill A: Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporation. Methods Mol Biol
  3. (2010). DJ: Highly effi cient reprogramming to pluripotency and directed diff erentiation of human cells with synthetic modifi ed mRNA. Cell Stem Cell
  4. (2010). Hochedlinger K: Induced pluripotency: history, mechanisms, and applications. Genes Dev
  5. (2011). Human embryonic stem cells with biological and Li et al.
  6. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fi broblast cultures by defi ned factors. Cell
  7. (2011). Loring JF: Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell
  8. (2007). mRNA-mediated gene delivery into human progenitor cells promotes highly effi cient protein expression. J Cell Mol Med
  9. (2009). S: Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol
  10. Zhang K: Somatic coding mutations in human induced pluripotent stem cells. Nature 2011, in press. doi:10.1186/scrt46 Cite this article as: Li M, et al.: Cell fate conversion by mRNA.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.